Page 7 - Practical Considerations to Health Professional-Led Advocacy

Learning Objectives

By the end of this program, participants will have a practical

understanding of health care policy-making in Canada, with a focus on

prescription drugs, including:

• The regulatory process (Health Canada)

• Health Technology Assessment

• Private payers

• How provinces negotiate prices for drugs

• The ethical frameworks for HP led advocacy

• The difference between advocacy and lobbying

• Clinician Input Process (pCODR)

• Using Real World Evidence to inform reimbursement policy and
decision-making (case study)